IC-MedTech seeks partnerships or out-licensing for clinical testing and commercialization of Apatone across a range of indications. The company’s primary focus is on treating neoplastic diseases using Apatone in the adjuvant setting.

Our mission is to develop affordable therapeutic options that are both safe and effective. Companies interested in our research are encouraged to contact for more information.